Overview
Butyrate Therapy in Pediatric UC
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2027-06-30
2027-06-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.Phase:
Phase 1Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Children's Hospital Los Angeles
Criteria
Inclusion Criteria:- 7-21 years, mild to moderate ulcerative colitis
Exclusion Criteria:
- UC therapy within 4 weeks of study medication initiation
- infectious colitis, -pregnancy